FIGURE 1.

Schematic of the study design. Patients with AUD without known liver disease admitted to the hospital for non–liver-related complaints were enrolled during hospitalization. The treatment group was evaluated by both addiction medicine and ALivE. The standard-of-care group consisted of a historical cohort of patients with AUD admitted 1 year before the creation of ALivE and therefore were evaluated by addiction medicine alone. Important liver-related outcomes at the time of discharge and 3- and 6-month follow-up were analyzed. Abbreviations: AUD, alcohol use disorder; ALiVE, alcohol liver evaluation team.